RdJ detection tests to identify a unique MRSA clone of ST105-SCC mec II lineage and its variants disseminated in the metropolitan region of Rio de Janeiro

RdJ 检测测试用于识别在里约热内卢大都市区传播的 ST105-SCC mec II 谱系的独特 MRSA 克隆及其变体

阅读:5
作者:Matheus Assis Côrtes Esteves, Alice Slotfeldt Viana, Gabriela Nogueira Viçosa, Ana Maria Nunes Botelho, Ahmed M Moustafa, Felipe Raposo Passos Mansoldo, Adriana Lucia Pires Ferreira, Alane Beatriz Vermelho, Bernadete Teixeira Ferreira-Carvalho, Paul Joseph Planet, Agnes Marie Sá Figueiredo

Abstract

Hospital bloodstream infection (BSI) caused by methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of morbidity and mortality and is frequently related to invasive procedures and medically complex patients. An important feature of MRSA is the clonal structure of its population. Specific MRSA clones may differ in their pathogenic, epidemiological, and antimicrobial resistance profiles. Whole-genome sequencing is currently the most robust and discriminatory technique for tracking hypervirulent/well-adapted MRSA clones. However, it remains an expensive and time-consuming technique that requires specialized personnel. In this work, we describe a pangenome protocol, based on binary matrix (1,0) of open reading frames (ORFs), that can be used to quickly find diagnostic, apomorphic sequence mutations that can serve as biomarkers. We use this technique to create a diagnostic screen for MRSA isolates circulating in the Rio de Janeiro metropolitan area, the RdJ clone, which is prevalent in BSI. The method described here has 100% specificity and sensitivity, eliminating the need to use genomic sequencing for clonal identification. The protocol used is relatively simple and all the steps, formulas and commands used are described in this work, such that this strategy can also be used to identify other MRSA clones and even clones from other bacterial species.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。